Michele Bartoletti

10PUBLICATIONS
79CO-AUTHORS
Medical infection agents (incl. prions)Social epidemiologyBiological adaptationImmunogenetics (incl. genetic immunology)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2025
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections.

Nicholas Geremia, Federico Giovagnorio, Antonio Vena

|Jun 27, 2025
What Is the Impact of Anti-Enterococcal Empirical Therapy on Survival of Patients With Enterococcal Bloodstream Infections?

Linda Bussini, Davide F Bavaro, Enrico Brunetta

|May 05, 2025
The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications.

Stefano Di Bella, Bruna Marini, Giacomo Stroffolini

|Feb 28, 2025
Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper.

Angelo Valerio Marzano, Michele Bartoletti, Vincenzo Bettoli

|Oct 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19.

Andre C Kalil, Aastha Chandak, Luke S P Moore

|Sep 01, 2023
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape.

Antonio Vena, Matteo Bassetti, Laura Mezzogori

Pageof 2

Frequent Collaborators

3 joint publications

Daniele Roberto Giacobbe

2 joint publications

Matteo Bassetti

2 joint publications

Nicholas Geremia

2 joint publications

Zeno Pasquini